Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.107 | uM | 12379.167 | 0.9824 | 0.9331 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.533 | uM | 12379.167 | 0.9736 | 0.8999 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 2.67 | uM | 12379.167 | 1.0285 | 1.1107 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12379.167 | 0.9466 | 0.8000 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12379.167 | 0.9196 | 0.7027 | 0.5212 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10938.154 | 0.8860 | 0.7807 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10938.154 | 0.8109 | 0.6357 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10938.154 | 0.9051 | 0.8176 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10938.154 | 0.8347 | 0.6817 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10938.154 | 0.8632 | 0.7368 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10938.154 | 0.8205 | 0.6543 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10938.154 | 0.8376 | 0.6873 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10938.154 | 0.9080 | 0.8231 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10938.154 | 0.8684 | 0.7468 | 1.0425 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000171 | uM | 12333.167 | 0.9025 | 0.7203 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000853 | uM | 12333.167 | 0.9426 | 0.8337 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00427 | uM | 12333.167 | 1.0307 | 1.0909 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0213 | uM | 12333.167 | 0.8879 | 0.6796 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.107 | uM | 12333.167 | 0.9405 | 0.8278 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.533 | uM | 12333.167 | 0.9187 | 0.7659 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 2.67 | uM | 12333.167 | 0.8798 | 0.6571 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12333.167 | 0.8385 | 0.5442 | 0.6809 | |
MDA-MB-415 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12333.167 | 0.8763 | 0.6474 | 0.6809 | |
MDA-MB-453 | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000171 | uM | 12414.167 | 0.9575 | 0.9297 | 1.2130 | |
MDA-MB-453 | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000853 | uM | 12414.167 | 0.9962 | 0.9938 | 1.2130 |